ask="1.090"
ask_size="600"
average_daily_volume="105077"
bid="0.950"
bid_size="1000"
book_value="0.531"
change="-0.048"
change_from_200_day_moving_average="-0.444"
change_from_50_day_moving_average="-0.229"
change_from_52_week_high="-6.958"
change_From_52_week_low="0.072"
change_in_percent="-4.615%"
close="0.992"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.010"
ebitda="-15.83M"
eps_estimate_current_year="-0.820"
eps_estimate_next_quarter="-0.220"
eps_estimate_next_year="-0.730"
ex_dividend_date="N/A"
float_shares="6119000"
high="1.040"
high_52_weeks="7.950"
last_trade_date="3/1/2017"
last_trade_price="0.992"
last_trade_size="100"
last_trade_time="3:58pm"
low="0.960"
low_52_weeks="0.920"
market_capitalization="16.26M"
moving_average_200_day="1.436"
moving_average_50_day="1.221"
name="Bioblast Pharma Ltd."
notes="N/A"
one_year_target_price="9.000"
open="1.010"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-30.909%"
percent_change_from_50_day_moving_average="-18.724%"
percent_change_from_52_week_high="-87.522%"
percent_change_from_52_week_low="+7.803%"
previous_close="1.040"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.959"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="1.590"
stock_exchange="NGM"
symbol="ORPN"
volume="180048"
weeks_range_52="0.920 - 7.950"
